Similar Articles
lron Deficiency and Restless Legs Syndrome; Three Cases
C. TOGAY IŞIKAY, A. BİNGÖL, N. MUTLUER
Subacute Myleo-Optic Neuropathy- Case Report
Egemen VARDARLI, Gürbüz GÜMÜŞDİŞ, Sevgi TAVUS
New Developments in Parkinson's Disease Management
M. Cenk AKBOSTANCI
Immunoglobulin Treatment and Electrophysiological Findings in -Guillain-Barrè Syndrome
Münevver ÇELİK, Buket OFLAZOĞLU, Hulki FORTA
Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.
Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA
THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS
Bülent ELİBOL
Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN
Guillain-Barré Syndrome with Bilateral Peripheral Facial Nerve Paralysis After COVID-19 Infection
Özgül Ocak
DOI: 10.4274/tnd.2021.78095
A Case Report of Acute Disseminated Encephalomyelitis in a Pregnant Woman After COVID-19 Infection
Rukiye Kızılırmak, Miraç Özalp, Mehmet Armağan Osmanağaoğlu, Cavit Boz
DOI: 10.4274/tnd.2021.25675
Guillain-Barré Syndrome and COVID-19 Vaccines: A Comment
Joob Beuy, Viroj Wiwanitkit
DOI: 10.4274/tnd.2021.47048
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU
A rare variant of Guillain-Barré syndrome: Isolated bilateral facial paralysis
Saniye Karabudak, Zeliha Matur, Aslı Yaman Kula, Vildan Güzel, Ferda İlgen Uslu
DOI: 10.55697/tnd.2024.151
Guillain-Barre syndrome: A single-center experience
Gülsüm Aslı Tatlı, Ekrem Sarıkaya, Özlem Kayım Yıldız
DOI: 10.55697/tnd.2024.100
The potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment
Firat Karaaslan, Reşit Yilmaz, Fidel Demir, Müttalip Özbek, İbrahim Kaplan, Eşref Akil
DOI: 10.55697/tnd.2025.216